Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Yaël C. Cohen, Mor Zada, Shuang-Yin Wang, +25

Nature Medicine

Hematological MalignancyResistance PathwaysSingle Cell SequencingMedicineTherapeutic Targets +6

Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial

Ilana Oren, Hannah Sprecher, Renato Finkelstein, +15

American Journal of Infection Control

Antimicrobial SusceptibilityAntibioticsAntimicrobial TherapyMicrobiologyInfection Control +4

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

Emanuela Sant’Antonio, Paola Guglielmelli, Lisa Pieri, +32

American Journal of Hematology

Retrospective StudyThrombosisHematological MalignancyVenous ThrombosisSplanchnic Vein Thromboses +12

Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome

Emília Hardak, Irit Avivi, Lina Berkun, +5

Infection

Healthcare-associated InfectionHematologyPathologyRespiratory InfectionInfectious Respiratory Disease +8

Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies

Ronit Gurion, Uri Rozovski, Gilad Itchaki, +14

Haematologica

ImmunodeficienciesHumoral ResponseImmunologyPathologyImmunodominance +14

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study

Tamir Shragai, Hila Magen, Noa Lavi, +18

British Journal of Haematology

Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study

Eli Muchtar, Moshe E. Gatt, Ory Rouvio, +11

British Journal of Haematology

Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy

Ofrat Beyar‐Katz, Ksenia Magidey, Anat Reiner‐Benaim, +11

Molecular Cancer Research

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome

Ilana Levy, Avital Lavi, Eran Zimran, +29

Leukemia & lymphoma/Leukemia and lymphoma

Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia

Yishai Ofran, Ronit Leiba, Chezi Ganzel, +15

American Journal of Hematology